Cancer cells acquire characteristics that promote growth, survival and dissemination, including dysregulation of cell cycle control, failure to respond to cell death signals, elicitation of angiogenesis and invasiveness. The most invasive cancer cells have invadopodia: actin-rich membrane protrusions that control pericellular proteolysis. Invadopodia are related to podosomes, which are elaborated in migratory differentiated cells such as phagocytes, vascular smooth muscle and endothelial cells. Although invadopodia are not required for cancer cell growth on tissue culture plastic, they facilitate growth in 3-dimensional collagen matrices. Furthermore, loss of invadopodia correlates with decreased tumorigenicity and dissemination in vivo. We hypothesized that key regulators of invadopodia were yet to be discovered. We set out to isolate these regulators, which may represent novel therapeutic targets. Many important oncology targets are kinases. Indeed, several kinase inhibitors are approved chemotherapeutic agents, and many others are in clinical testing. Most were selected on the basis of inhibition of cell cycle progression, cell survival or angiogenesis. Few studies have focused on kinases that regulate invasive cell behavior. Furthermore, there are few publications on most members of the human kinome, suggesting that this is an untapped resource for target identification. We therefore focused our search on kinases. We established a high content screening assay to quantify invadopodia in high throughput. We screened for invadopodia inhibitors in an siRNA library specific for the kinome, and identified 14 strong hits. To date we have focused on three of these hits. In preliminary studies we found that each is involved in invadopodia formation, and overexpressed in human cancer cells. Other kinases are at an earlier stage of validation. Thus we have developed a prioritized list of kinases with invadopodia functions, which may play roles in human tumor growth and progression. Our high content screening assay has provided us with a rich pipeline of kinase regulators, and we hypothesize that some of these kinases are novel therapeutic targets. We propose to further evaluate the therapeutic potential of our top hits, as well as extend our validation efforts to other kinases in the pipeline. The overarching significance of this research is the extraordinary opportunity to develop new therapeutic approaches to the treatment of disseminated cancers. The near term impact lies in the ability of this research to identify new molecular targets with novel mechanisms of action.

Public Health Relevance

The growth of disseminated cancers leads to morbidity and mortality, and there is an urgent unmet need for new therapeutic targets. This research seeks to identify kinases that mediate invasive behavior of cancer cells, and thus is of relevance to the public health problem of metastatic cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-OTC-D (02))
Program Officer
Forry, Suzanne L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Paterson, Elyse K; Courtneidge, Sara A (2018) Invadosomes are coming: new insights into function and disease relevance. FEBS J 285:8-27
Saini, Priyanka; Courtneidge, Sara A (2018) Tks adaptor proteins at a glance. J Cell Sci 131:
Eckert, Mark A; Santiago-Medina, Miguel; Lwin, Thinzar M et al. (2017) ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions. J Cell Sci 130:2036-2048
Iizuka, Shinji; Abdullah, Christopher; Buschman, Matthew D et al. (2016) The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. Oncotarget 7:78473-78486
Díaz, Begoña; Ostapoff, Katherine T; Toombs, Jason E et al. (2016) Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model. Oncotarget 7:51569-51580
Blouw, Barbara; Patel, Manishha; Iizuka, Shinji et al. (2015) The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo. PLoS One 10:e0121003
Burger, Karen L; Learman, Brian S; Boucherle, Amy K et al. (2014) Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells. Prostate 74:134-48
Díaz, Begoña; Yuen, Angela; Iizuka, Shinji et al. (2013) Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol 201:279-92
Courtneidge, Sara A (2012) Cell migration and invasion in human disease: the Tks adaptor proteins. Biochem Soc Trans 40:129-32
Quintavalle, Manuela; Elia, Leonardo; Price, Jeffrey H et al. (2011) A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal 4:ra49